NCT03347045

Brief Summary

Trimodal prehabilitation is a preoperative three-tiered (trimodal) approach to optimizing physical and mental health. It has been found to successfully improve functional recovery in patients undergoing colorectal surgery following an evidence-based enhanced-recovery pathway (ERP). It is unknown whether the same program is effective in patients undergoing a similar surgery for bladder cancer (radical cystectomy). Objective: To evaluate the appropriateness of a standardized prehabilitation program for implementation into an enhanced recovery pathway for cystectomy patients and determine whether prehabilitation facilitates earlier recovery of functional capacity. Hypothesis: Prehabilitation will ultimately improve recovery of functional capacity, clinical and patient-centered outcomes in patients undergoing radical cystectomy for bladder cancer. Design: Participants will follow an 8-week trimodal prehabilitation program consisting of exercise therapy combined with nutritional counseling, protein supplementation, and psychological care; they will be compared to a cohort of participants following ERP care alone. Conclusion: The proposal will provide insight into the feasibility and effectiveness of trimodal prehabilitation for radical cystectomy patients and may ultimately lead to improved clinical outcomes and reduced morbidity.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 20, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

January 15, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2019

Completed
Last Updated

November 20, 2017

Status Verified

November 1, 2017

Enrollment Period

1 year

First QC Date

November 14, 2017

Last Update Submit

November 16, 2017

Conditions

Keywords

cystectomynutritionphysiotherapyprehabilitationenhanced recovery after surgery

Outcome Measures

Primary Outcomes (1)

  • 6-minute walk test (6MWT)

    The 6MWT is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.

    Multiple time-points over 20-weeks

Secondary Outcomes (6)

  • 10-meter walk test (10mWT)

    Multiple time-points over 20-weeks

  • 30s sit-to-stand test (30CST)

    Multiple time-points over 20-weeks

  • Hand-grip dynamometry

    Multiple time-points over 20-weeks

  • Functional Assessment of Cancer Therapy for Bladder Cancer (FACT-Bl)Questionnaire

    Collected at beginning and end of 20-week participant involvement period

  • EuroQOL five dimensions (EQ-5D) Questionnaire

    Collected at beginning and end of 20-week participant involvement period

  • +1 more secondary outcomes

Other Outcomes (3)

  • Length of hospital stay (LOS)

    Collected at the finale of participant-involvement (20-weeks)

  • 30 day readmission rate

    Collected at the finale of participant-involvement (20-weeks)

  • Clavien-Dindo classification of Surgical Complications

    Collected at the finale of participant-involvement (20-weeks)

Study Arms (2)

Trimodal Prehab & ERP

EXPERIMENTAL

Trimodal prehab includes: 1. Guided exercise program at Repsol Place in Calgary, Alberta 2x/week, hosted by the Total Cardiology group. Home-exercise program for another 3x/week. 2. Nutritional optimization with a high-protein oral supplement, along with nutritional counseling and access to a Registered Dietitian on site. 3. Anxiety reduction workshop and take-home anxiety reduction program.

Combination Product: Trimodal Prehab & ERP

No Prehab; ERP Alone

ACTIVE COMPARATOR

The active comparator group will be given a home exercise program, nutrition education, and a take-home anxiety reduction program.

Other: No Prehab; ERP Alone

Interventions

Trimodal Prehab & ERPCOMBINATION_PRODUCT

1-hr daily exercise will be completed a total of 5d/week, of which 2 of these sessions are completed through a community fitness center. Following these sessions, the participant will consume a high-protein oral supplement. Additionally, during the program, participants will be given the option of attending a stress-reduction group and will receive a take-home anxiety-reduction program. They will have access to a physiotherapist, kinesiologist, registered dietitian, and physician throughout the program. The total length of this program is 8-weeks and is timed to occur in the waiting period between the consent for surgery and operation date.

Also known as: Trimodal prehab and enhanced-recovery pathway (ERP) together
Trimodal Prehab & ERP

1-hr daily exercise with a self-completed home-exercise program. The participant will be given nutritional education material and a take-home anxiety-reduction program. They will be responsible for maintaining a journal of their activity.

Also known as: No trimodal prehab; enhanced-recovery pathway (ERP) alone
No Prehab; ERP Alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female ≥ 18 years of age at time of consent for surgery.
  • Documentation of bladder cancer diagnosis as evidenced by diagnostic imaging and biopsy.
  • May or may not receive adjuvant therapy.
  • Written informed consent obtained from subject

You may not qualify if:

  • Presence of a condition or abnormality that in the opinion of the investigator would compromise the safety of the patient or adherence to the program. This includes:
  • American Society of Anesthesiologists (ASA) health class status 4-5;
  • Co-morbid medical, physical, and/or mental conditions including dementia, disabling orthopedic and neuromuscular disease, psychosis;
  • Severe cardiac abnormalities, end-stage organ disease, sepsis, or morbid obesity (BMI greater than 35);
  • Undergoing radical cystectomy for a reason other than bladder cancer.
  • Poor comprehension of English or French
  • Screened by Total Cardiology staff and determined to be inappropriate for prehabilitation at their facility.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Interventions

Single Person

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Marital StatusFamily CharacteristicsDemographyPopulation CharacteristicsSocioeconomic Factors

Study Officials

  • Jason Martyn, MScPT

    Alberta Health services

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jason Martyn, MScPT

CONTACT

Chelsia Gillis, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessor blinding; due to the nature of the study, participant, care provider \& investigator cannot be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single-center pragmatic randomized-control trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

November 14, 2017

First Posted

November 20, 2017

Study Start

January 15, 2018

Primary Completion

January 15, 2019

Study Completion

July 15, 2019

Last Updated

November 20, 2017

Record last verified: 2017-11